JPRN-UMIN000002895招募中未知
ilotinib pharmacokinetics correlation with clinical response and adverse events in chronic myelogenous leukemia - nilotinib pahrmacokinetics in Japanese CML patients
Hyogo College of Medicine/Division of Hematology, Department of Internal Medicine0 个研究点目标入组 30 人开始时间: 2009年12月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients suspected in blast crisis 2.History of a invasive double cancer within 5 years before 3.Pregnant and/or lactating woman 4.Severe psychological disorders 5.Uncontorlled complications
研究者
相似试验
已完成
不适用
Imatinib pharmacokinetics and its correlation with response in chronic-phase chronic myelogenous leukemiachronic myelogenous leukemia in chronic-phaseJPRN-UMIN000001125Keio University School of Medicine60
招募中
不适用
Imatinib pharmacokinetics and its correlation with response and safety in Indian children and adults with chronic phase chronic myeloid leukemia.CTRI/2010/091/000190Terry Fox Fooundation150
已完成
不适用
[11C]Erlotinib pharmacokinetics: an in vivo study using positron emission tomography in non-small cell lung cancer patients with and without erlotinib therapy.non-small cell lung carcinoma10038666lung cancerNL-OMON36826Vrije Universiteit Medisch Centrum10
已完成
1 期
A Clinical Trial to Evaluate the Effect of Nilotinib on the PK/PD of MeforminHealthyNCT04448821Hyewon Chung16
已完成
4 期
Population Pharmacokinetics study of ImatinibChronic myeloid leukaemia (CML).Chronic myeloid leukaemia [CML], BCR/ABL-positiveIRCT2014050612206N1Kerman University of Medical Sciences220